1st World Conference on Targeting Liver Diseases - Jerusalem, Israel - June 26-27, 2014

Liver Innovation Platform For Biotech Teams, Startup and Investors - The Liver Investor Network

Investors

The Liver Investor Network is an investor and partnering platform devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place during Jerusalem meeting.

Come and present, discuss, exchange and initiate a collaboration with Israeli and international leaders and actors of liver world.

The Microbiome and Liver Disease – Towards a new understanding

Thiais

The liver receives the majority of its blood supply from the portal vein, and thus represents the first pass organ for food antigents and products derived from the intestinal microbiota. The team of Dr Christoph Thaiss, from Weizmann Institute of Science, Israel has recently demonstrated that this microbiota-liver axis plays a fundamental role in the initiation and progression of hepatic disease.

Hepatic Paraoxonase-1 (PON1) Regulation: Recent Advances & Perspectives

Dr Bianca Fuhrman from The Lipid Research Laboratory, Technion Faculty of Medicine and Rambam Health Care Campus, Haifa, Israel will highlight the Recent Advances & Perspectives of Hepatic Paraoxonase-1 (PON1) Regulation during Targeting Liver Diseases World Congress 2014.

Vitamin E and Diabetic Nephropathy; Lessons and Clinical Implications

Nakhoul2 In diabetes mellitus there is an increase in oxygen radical formation due to glucose auto oxidation, the formation of advanced glycosylation end products, and metabolic stress. Epidemiologic studies suggest that vitaminE supplementation might decrease the risk of developing cardiovascular disease, others showed increased risk of cardiac death with the vitamin E treatment.

Liver repopulation following toxic liver injury - which genes have most impact?

Kaestner

Prior research on hepatocyte proliferation has focused on the easily accessible paradigm of partial hepatectomy, which does not model the regenerative response of hepatocytes following toxic injury, such as occurs following alcohol or acetaminophen poisoning.

More Articles...

Page 2 of 3

<< Start < Prev 1 2 3 Next > End >>

HadassahMedical Center

IsraelAssociationfortheStudyofLiver

Targeting Liver 2014 was a Huge Success
Dear Colleagues,
It was a great pleasure to meet you for the First World Conference on Targeting Liver Diseases: Sciences, Clinical Innovation & Biotechnology which was held...
Read More...
Pr Mehmet Ozturk was awarded by Targeting Liver 2014 Scientific Committee for his Scientific Contribution
The Winner of Targeting Liver 2014 Pr Mehmet Ozturk, from Dokuz Eylul University, Turkey was awarded for his Scientific Contribution by ISANH Scientific Committee during the 1st International Conference...
Read More...
Dr Firtina Karagonlar was awarded by Targeting Liver 2014 Scientific Committee for her Poster Contribution
Dr Firtina Karagonlar, from Dokuz Eylul University, Turkey was awarded for her Poster Contribution by ISANH Scientific Committee during the 1st International Conference on Targeting Liver Diseases, which...
Read More...
The Abstracts Book of the first World Conference on Targeting Liver Diseases is now available
The first edition of Targeting Liver Diseases World Conference was a success in term of scientific presentations and discussion. The abstracts book of the conference groups all abstracts of oral...
Read More...
An update in viral hepatitis lecture will be given by Pr Assy Nimer
Pr Assy Nimer, Director of Liver Services & Senior Lecturer at Ziv Medical Center, Safed, Israel will give a lecture, during the first world congress on targeting liver diseases, to update the recent...
Read More...
The Committees of Targeting Liver Diseases 2014 thank BMS and Janssen for their supporting
The scientific committee would like to thanks Bristol-Myers Squibb and Janssen for their supporting Targeting Liver Diseases Conference. Without their sponcoring the ocnference will not be held in favorable...
Read More...
Special Rates for your Booking at Dan Jerusalem Hotel for Targeting Liver 2014
Special Booking Rates Targeting Liver 2014 & Dan Jerusalem Hotel offer you special rates for your booking for Targeting Liver 2014. To...
Read More...
The updated program of Targeting Liver Diseases World Congress 2014 is now available
On behalf of Scientific Committee, we are pleased to inform you that the program of Targeting Liver Diseases World Congress, which will be held in Jerusalem on June 26-27 is now available.
Read More...